Management of cardiac electrical storm: a case report

Authors

  • Olajide O. Oresegun Tristate Cardiovascular Associates, Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria
  • Kamar T. Adeleke Tristate Cardiovascular Associates, Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria
  • Michael O. Sanusi Georgia Arrhythmia Consultants and Research Institute, Macon, Georgia, United States of America
  • Morenikeji E. Oluwaferanmi Tristate Cardiovascular Associates, Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria
  • Felix O. Sogade Georgia Arrhythmia Consultants and Research Institute, Macon, Georgia, United States of America

DOI:

https://doi.org/10.18203/2349-3933.ijam20222666

Keywords:

Cardiac electrical storm, Implantable cardioverter defibrillator, Structural heart disease

Abstract

There is a steady increase in the incidence of intra-cardiac device complications in patients with structural heart diseases. Cardiac electrical storm is associated with deleterious clinical and psychological sequelae. Management can be challenging in a resource-poor environment. Old anti-arrhythmic medications can still be effective when conventional ones fail. 

 

Author Biography

Olajide O. Oresegun, Tristate Cardiovascular Associates, Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria

Consultant Cardiologist

References

Moss AJ, Zareba W, Hall WJ. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J. Med. 2002;346;877-83.

Schulz SM, Massa C, Grzbiela A. Implantation Cardioverter defibrillator shocks are prospective predictors of anxiety. Heart lung. 2013;42:105-11.

European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE et al. ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of patients with Ventricular Arrhythmias and the prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48(5):e247-346.

Bardy GH, Lee KL, Mark DB. Amiodarone or an Implantable Cardioverter Defibrillator for congestive heart failure. N Engl J Med. 2005;352;225-37.

Poole JE Johnson GW, Hellkamp AS. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-17.

Mahajan A, Moore J, Cesario DA, Shivkumar K. Use of thoracic epidural anaesthesia for management of electrical storm. Heart Rhythm. 2005;2(12):1359-62.

Golian M, Bhagirath KM, Sapp JL. Idiopathic ventricular fibrillation controlled successfully with phenytoin. J. Cardiovasc Electrophysiol. 2011;22:472-4.

Kannakeril PJ, Roden DM. Drug-induced long QT and Torsades de pointes: Recent advances. Curr Poin Cardiol. 2007;22:39-43.

Scheuer T, Kass RS. Phenytoin reduces calcium current in the cardiac purkinje fiber. Circ Res. 1983;53:16-23.

Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation. 2000;102(7):742-7.

Downloads

Published

2022-10-26

Issue

Section

Case Reports